beta
/A phase 1 study to evaluate safety, tolerability, and pharmacokinetics of LNP8701 (SOS1 inhibitor) in subjects with metastatic solid tumors.
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Data not found

Cited By (0)